
Glimoris-MP 1 Tablet ER
Marketer
Curis Lifecare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimoris-MP 1 Tablet ER
Glycemic Control ER, a single-dose combination medication, aids in managing blood glucose. This treatment, used alongside diet and exercise, enhances blood sugar regulation in adults with type 2 diabetes. It facilitates improved insulin use, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and regimen for Glycemic Control ER. Take it with food to minimize stomach discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. Overdosage can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals may trigger hypoglycemia. Regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Before initiating treatment, inform your doctor of any kidney, liver, or heart conditions. Pregnant or lactating individuals should consult their doctor. Kidney function tests will be conducted prior to commencing therapy. Limit alcohol consumption, as this may increase the likelihood of adverse effects.
Uses of Glimoris-MP 1 Tablet ER
Managing type 2 diabetes
Major Benefits of Glimoris-MP 1 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimoris-MP 1 Tablet ER with a meal.
Common Side effects of Glimoris-MP 1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimoris-MP 1 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take one extended-release Glimoris-MP tablet with a meal.
How Glimoris-MP 1 Tablet ER works:
Glimoris-MP 1 Extended-Release tablet combines three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. These medications employ diverse actions to enhance blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Glimoris-MP 1 Tablet ER ingestion poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Glimoris-MP 1 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimoris-MP tablets (1 mg) are likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Glimoris-MP 1 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. The use of Glimoris-MP 1 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended throughout the treatment period.
LiverCAUTION
Exercise caution when prescribing Glimoris-MP 1 Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Glimoris-MP 1 Tablet ER is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Glimoris-MP 1 Tablet ER :
Should you forget a dose of Glimoris-MP 1 Tablet ER, take it immediately if possible. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimoris-MP 1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
